Nature:GDF15介导二甲双胍对体重和能量平衡的效应

2020-01-04 xing.T MedSci原创

总之,二甲双胍可提高循环中GDF15的水平,这对于其维持能量平衡和体重的有益作用是必需的,而GDF15作为其化学预防剂具有主要作用。

二甲双胍是世界上最广泛运用到处方中的抗糖尿病药物,也可有效预防高危人群中的2型糖尿病。这种作用60%以上归因于二甲双胍持续降低体重的功能。二甲双胍降低体重的分子机制尚不清楚。

近日,顶级期刊Nature上发表了一篇研究文章,在两项独立的随机对照临床试验中,二甲双胍可提高受试者循环中GDF15的水平,最近研究发现二甲双胍通过脑干限制性受体来减少食物摄入并降低体重。

在野生型小鼠中,口服二甲双胍可增加循环中的GDF15水平,而GDF15主要在远端肠道和肾脏中表达增加。在野生型小鼠中,二甲双胍阻止了高脂饮食诱导的体重增加,但在缺乏GDF15或其受体GFRAL的小鼠中却没有。在肥胖的高脂饮食小鼠中,二甲双胍减轻体重的作用被GFRAL拮抗剂抗体所逆转。二甲双胍需要GDF15才能对能量摄入和能量消耗产生效应。在没有GDF15作用的情况下,二甲双胍保持了降低循环葡萄糖水平的能力。

总之,二甲双胍可提高循环中GDF15的水平,这对于其维持能量平衡和体重的有益作用是必需的,而GDF15作为其化学预防剂具有主要作用。

原始出处:

Anthony P. Coll. et al. GDF15 mediates the effects of metformin on body weight and energy balance.Nature.2020.https://www.nature.com/articles/s41586-019-1911-y.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=959338, encodeId=2f14959338f7, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210401/872a23176a1943aa98debee983ae0459/c42fb22ba7ae4c3aa4d2fdcef7280211.jpg, createdBy=a17d5432593, createdName=ms1000000765466241, createdTime=Thu Apr 22 11:12:45 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896638, encodeId=8bf2896638d2, content=<a href='/topic/show?id=46f3e900ee' target=_blank style='color:#2F92EE;'>#GDF-15#</a>是长寿因子,<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a>抗<a href='/topic/show?id=4c239032154' target=_blank style='color:#2F92EE;'>#衰老#</a>,可能与它也有关, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7900, encryptionId=46f3e900ee, topicName=GDF-15), TopicDto(id=23982, encryptionId=ce9d239823b, topicName=二甲双胍), TopicDto(id=90321, encryptionId=4c239032154, topicName=衰老)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Nov 03 16:09:25 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884069, encodeId=992e1884069ca, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jul 07 04:19:00 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509650, encodeId=e638150965071, content=<a href='/topic/show?id=ed198428ef9' target=_blank style='color:#2F92EE;'>#能量平衡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84287, encryptionId=ed198428ef9, topicName=能量平衡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a610121508, createdName=zxl732, createdTime=Mon Jan 06 08:19:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041503, encodeId=e002104150323, content=二甲双胍,神药!, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Jan 04 20:19:00 CST 2020, time=2020-01-04, status=1, ipAttribution=)]
    2021-04-22 ms1000000765466241

    受教了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=959338, encodeId=2f14959338f7, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210401/872a23176a1943aa98debee983ae0459/c42fb22ba7ae4c3aa4d2fdcef7280211.jpg, createdBy=a17d5432593, createdName=ms1000000765466241, createdTime=Thu Apr 22 11:12:45 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896638, encodeId=8bf2896638d2, content=<a href='/topic/show?id=46f3e900ee' target=_blank style='color:#2F92EE;'>#GDF-15#</a>是长寿因子,<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a>抗<a href='/topic/show?id=4c239032154' target=_blank style='color:#2F92EE;'>#衰老#</a>,可能与它也有关, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7900, encryptionId=46f3e900ee, topicName=GDF-15), TopicDto(id=23982, encryptionId=ce9d239823b, topicName=二甲双胍), TopicDto(id=90321, encryptionId=4c239032154, topicName=衰老)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Nov 03 16:09:25 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884069, encodeId=992e1884069ca, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jul 07 04:19:00 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509650, encodeId=e638150965071, content=<a href='/topic/show?id=ed198428ef9' target=_blank style='color:#2F92EE;'>#能量平衡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84287, encryptionId=ed198428ef9, topicName=能量平衡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a610121508, createdName=zxl732, createdTime=Mon Jan 06 08:19:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041503, encodeId=e002104150323, content=二甲双胍,神药!, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Jan 04 20:19:00 CST 2020, time=2020-01-04, status=1, ipAttribution=)]
    2020-11-03 lovetcm

    #GDF-15#是长寿因子,#二甲双胍##衰老#,可能与它也有关

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=959338, encodeId=2f14959338f7, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210401/872a23176a1943aa98debee983ae0459/c42fb22ba7ae4c3aa4d2fdcef7280211.jpg, createdBy=a17d5432593, createdName=ms1000000765466241, createdTime=Thu Apr 22 11:12:45 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896638, encodeId=8bf2896638d2, content=<a href='/topic/show?id=46f3e900ee' target=_blank style='color:#2F92EE;'>#GDF-15#</a>是长寿因子,<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a>抗<a href='/topic/show?id=4c239032154' target=_blank style='color:#2F92EE;'>#衰老#</a>,可能与它也有关, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7900, encryptionId=46f3e900ee, topicName=GDF-15), TopicDto(id=23982, encryptionId=ce9d239823b, topicName=二甲双胍), TopicDto(id=90321, encryptionId=4c239032154, topicName=衰老)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Nov 03 16:09:25 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884069, encodeId=992e1884069ca, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jul 07 04:19:00 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509650, encodeId=e638150965071, content=<a href='/topic/show?id=ed198428ef9' target=_blank style='color:#2F92EE;'>#能量平衡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84287, encryptionId=ed198428ef9, topicName=能量平衡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a610121508, createdName=zxl732, createdTime=Mon Jan 06 08:19:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041503, encodeId=e002104150323, content=二甲双胍,神药!, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Jan 04 20:19:00 CST 2020, time=2020-01-04, status=1, ipAttribution=)]
    2020-07-07 liye789132251
  4. [GetPortalCommentsPageByObjectIdResponse(id=959338, encodeId=2f14959338f7, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210401/872a23176a1943aa98debee983ae0459/c42fb22ba7ae4c3aa4d2fdcef7280211.jpg, createdBy=a17d5432593, createdName=ms1000000765466241, createdTime=Thu Apr 22 11:12:45 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896638, encodeId=8bf2896638d2, content=<a href='/topic/show?id=46f3e900ee' target=_blank style='color:#2F92EE;'>#GDF-15#</a>是长寿因子,<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a>抗<a href='/topic/show?id=4c239032154' target=_blank style='color:#2F92EE;'>#衰老#</a>,可能与它也有关, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7900, encryptionId=46f3e900ee, topicName=GDF-15), TopicDto(id=23982, encryptionId=ce9d239823b, topicName=二甲双胍), TopicDto(id=90321, encryptionId=4c239032154, topicName=衰老)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Nov 03 16:09:25 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884069, encodeId=992e1884069ca, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jul 07 04:19:00 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509650, encodeId=e638150965071, content=<a href='/topic/show?id=ed198428ef9' target=_blank style='color:#2F92EE;'>#能量平衡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84287, encryptionId=ed198428ef9, topicName=能量平衡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a610121508, createdName=zxl732, createdTime=Mon Jan 06 08:19:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041503, encodeId=e002104150323, content=二甲双胍,神药!, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Jan 04 20:19:00 CST 2020, time=2020-01-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=959338, encodeId=2f14959338f7, content=受教了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210401/872a23176a1943aa98debee983ae0459/c42fb22ba7ae4c3aa4d2fdcef7280211.jpg, createdBy=a17d5432593, createdName=ms1000000765466241, createdTime=Thu Apr 22 11:12:45 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896638, encodeId=8bf2896638d2, content=<a href='/topic/show?id=46f3e900ee' target=_blank style='color:#2F92EE;'>#GDF-15#</a>是长寿因子,<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a>抗<a href='/topic/show?id=4c239032154' target=_blank style='color:#2F92EE;'>#衰老#</a>,可能与它也有关, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7900, encryptionId=46f3e900ee, topicName=GDF-15), TopicDto(id=23982, encryptionId=ce9d239823b, topicName=二甲双胍), TopicDto(id=90321, encryptionId=4c239032154, topicName=衰老)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Tue Nov 03 16:09:25 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884069, encodeId=992e1884069ca, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Jul 07 04:19:00 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509650, encodeId=e638150965071, content=<a href='/topic/show?id=ed198428ef9' target=_blank style='color:#2F92EE;'>#能量平衡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84287, encryptionId=ed198428ef9, topicName=能量平衡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0a610121508, createdName=zxl732, createdTime=Mon Jan 06 08:19:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1041503, encodeId=e002104150323, content=二甲双胍,神药!, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Sat Jan 04 20:19:00 CST 2020, time=2020-01-04, status=1, ipAttribution=)]
    2020-01-04 misszhang

    二甲双胍,神药!

    0

相关资讯

SCI REP:血浆GDF15水平与精神疾病严重程度呈负相关!

该研究的结果表明抗炎的GDF15减少介导了严重的精神疾病。但需要在更大的队列研究中进行重复,以评估GDF15在精神疾病中作为评估预后生物标志物的潜在作用。

Liver Int:生长分化因子15预测NAFLD患者进展期肝纤维化

总之,研究表明,GDF15可以作为进展期肝纤维化的一种新的生物标志物。

Cell Death Dis:上皮细胞衍生的细胞因子CST3和GDF15可作为肺纤维化的潜在治疗剂

当伤口愈合完成时,上皮细胞通过消除基质重建期间激发的成纤维细胞来使间质环境标准化。否则,组织会发生病理性纤维化。肺纤维化是一种致命的,难以治愈的疾病。我们在此尝试鉴定能够改善肺纤维化的上皮衍生细胞因子。人肺成纤维细胞在上皮细胞条件培养基中失活。胱抑素C(CST3)和生长分化因子15(GDF15)在条件培养基中富集并通过失活TGF-Smad通路来抑制肺成纤维细胞的生长和活化。具有间质纤维化的小鼠和人

ADA 2019:打破认知界限,班廷奖获得者介绍二甲双胍改善代谢新机制

编者按:2019年美国糖尿病协会(ADA)年会上,神奇的二甲双胍再次成为万众瞩目的焦点。班廷奖得主英国剑桥大学临床生物化学与医学教授Stephen O'Rahilly在其获奖主题演讲中介绍了二甲双胍通过调控生长分化因子15(GDF15)改善代谢的新机制,令人耳目一新。数项最新研究成果显示了二甲双胍在治疗2型糖尿病(T2DM)、1型糖尿病(T1DM)、老年糖尿病、肿瘤等方面的作用机制及应用,进一步拓

Sci Rep:GDF15或可用于大块骨缺损的修复

大块骨缺损的修复仍然是目前临床上外科医生面临的一大挑战,采用组织工程学的方法进行修复是一种很有前途的方法。然而,其效果受到支架中部区域延迟血管化的限制。研究发现生长分化因子15(GDF15)是一个潜在的血管生成的细胞因子,可促进人脐静脉内皮细胞(HUVEC)的增殖。但是目前尚不清楚GDF15能否应用于促进血管化骨再生。本研究中,研究人员发现GDF15可增强细胞周期蛋白D1和E的表达,诱导Rb磷酸化

Aging Cell:衰老组织微环境通过分泌因子GDF15促进结肠癌的形成

结直肠癌(CRC)的风险因人而异,调节风险差异的细胞机制在很大程度上是未知的。